A detailed history of Deutsche Bank Ag\ transactions in Pep Gen Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 8,246 shares of PEPG stock, worth $29,932. This represents 0.0% of its overall portfolio holdings.

Number of Shares
8,246
Previous 6,725 22.62%
Holding current value
$29,932
Previous $107,000 34.58%
% of portfolio
0.0%
Previous 0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$7.75 - $18.55 $11,787 - $28,214
1,521 Added 22.62%
8,246 $70,000
Q2 2024

Aug 14, 2024

BUY
$10.54 - $18.14 $26,307 - $45,277
2,496 Added 59.02%
6,725 $107,000
Q1 2024

May 15, 2024

BUY
$6.63 - $17.3 $28,038 - $73,161
4,229 New
4,229 $62,000
Q2 2023

Aug 14, 2023

SELL
$8.94 - $16.39 $20,848 - $38,221
-2,332 Reduced 24.84%
7,055 $63,000
Q1 2023

May 15, 2023

BUY
$11.44 - $17.7 $33,267 - $51,471
2,908 Added 44.88%
9,387 $114,000
Q4 2022

Feb 13, 2023

BUY
$9.31 - $16.57 $28,842 - $51,333
3,098 Added 91.63%
6,479 $86,000
Q3 2022

Nov 14, 2022

SELL
$4.86 - $12.75 $2,711 - $7,114
-558 Reduced 14.17%
3,381 $31,000
Q2 2022

Aug 11, 2022

BUY
$9.0 - $12.89 $35,451 - $50,773
3,939 New
3,939 $39,000

Others Institutions Holding PEPG

About PepGen Inc.


  • Ticker PEPG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 23,631,900
  • Market Cap $85.8M
  • Description
  • PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is a...
More about PEPG
Track This Portfolio

Track Deutsche Bank Ag\ Portfolio

Follow Deutsche Bank Ag\ and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.